Clinical Trial Update: Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Ga-DOTATOC PET sensitivity to Octreoscan SPECT+CT in medulloblastoma and related neuroendocrine tumors; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Medulloblastoma
• Medulloblastoma
• Neuroblastoma
• Neuroendocrine Tumor
• Somatostatinoma

Drugs mentioned

• Ga-DOTATOC (gallium-68 DOTATOC)
• OCTREOSCAN (Indium-111 pentetreotide)

Snippet

Sponsor: Sue O'Dorisio | Conditions: Adult Medulloblastoma, Childhood Medulloblastoma | Phase 2 | Status: COMPLETED | Results posted: 2021-09-22